Literature DB >> 2002169

The influence of systematic primary-tone level variation L2-L1 on the acoustic distortion product emission 2f1-f2 in normal human ears.

R Hauser1, R Probst.   

Abstract

The purpose of the present study was to determine the effect of primary-tone level variation, L2--L1, on the amplitude of distortion-product otoacoustic emissions (DPOAEs). The DPOAE at the frequency 2f1--f2 (f2 greater than f1) was measured in 20 ears of ten normally hearing subjects. Acoustic distortion products were generated by primaries f1 and f2 with geometric mean frequencies of 1, 2, and 4 kHz. The f2/f1 ratios were 1.25 (1 kHz), 1.23 (2 kHz), and 1.21 (4 kHz). The primary-tone level L1 was kept constant at either 65 or 75 dB SPL while the second primary-tone level L2 was varied between 20 and 90 dB SPL in 5-dB steps. The level differences L2--L1 generating maximal DPOAE amplitudes depended on L1 and on the geometric mean frequency of f1 and f2. There were large interindividual differences. Overall, the L2--L1 evoking maximal mean DPOAE amplitudes was --10 dB for geometric mean frequencies of 1 and 2 kHz with both L1 = 65 dB SPL and L1 = 75 dB SPL. For 4 kHz, L2-L1 was --5 dB with L1 = 65 dB SPL and 0 dB with L1 = 75 dB SPL. The mean slopes of the DPOAE growth functions in the initial linearly increasing portions were steeper at higher stimulus frequencies, increasing from 0.52 at 1 kHz to 0.72 at 4 kHz for L1 = 65 dB SPL and from 0.48 at 1 kHz to 0.72 at 4 kHz for L1 = 75 dB SPL.

Entities:  

Mesh:

Year:  1991        PMID: 2002169     DOI: 10.1121/1.400511

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  12 in total

1.  Distortion-product otoacoustic emission measured with continuously varying stimulus level.

Authors:  Stephen T Neely; Tiffany A Johnson; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2005-03       Impact factor: 1.840

2.  Influence of primary-level and primary-frequency ratios on human distortion product otoacoustic emissions.

Authors:  Tiffany A Johnson; Stephen T Neely; Cassie A Garner; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2006-01       Impact factor: 1.840

3.  Comparing the optimal signal conditions for recording cubic and quadratic distortion product otoacoustic emissions.

Authors:  Lin Bian; Shixiong Chen
Journal:  J Acoust Soc Am       Date:  2008-12       Impact factor: 1.840

Review 4.  Focal adhesion kinase and endothelial cell apoptosis.

Authors:  Qing Lu; Sharon Rounds
Journal:  Microvasc Res       Date:  2011-05-19       Impact factor: 3.514

5.  Optimizing distortion product otoacoustic emission recordings in normal-hearing ears by adopting cochlear place-specific stimuli.

Authors:  Samantha Stiepan; Shawn S Goodman; Sumitrajit Dhar
Journal:  J Acoust Soc Am       Date:  2022-08       Impact factor: 2.482

6.  Click- and tone-burst-evoked otoacoustic emissions in normally hearing ears and in ears with high-frequency sensorineural hearing loss.

Authors:  R Hauser; R Probst; E Löhle
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

7.  Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.

Authors:  Tiffany A Johnson; Stephen T Neely; Judy G Kopun; Darcia M Dierking; Hongyang Tan; Michael P Gorga
Journal:  Ear Hear       Date:  2010-02       Impact factor: 3.570

8.  Distortion product otoacoustic emissions: comparison of sequential vs. simultaneous presentation of primary tones.

Authors:  U Ajith Kumar; Sandeep Maruthy; Vishwakarma Chandrakant
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2009-03-31

9.  Efferent modulation of pre-neural and neural distortion products.

Authors:  S B Smith; K Ichiba; D S Velenovsky; B Cone
Journal:  Hear Res       Date:  2017-10-26       Impact factor: 3.208

10.  Stream segregation in the perception of sinusoidally amplitude-modulated tones.

Authors:  Lena-Vanessa Dolležal; Rainer Beutelmann; Georg M Klump
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.